4.4 Article

Gastrointestinal Surgery for Obesity and Diabetes: Weight Loss and Control of Hyperglycemia

Journal

CURRENT ATHEROSCLEROSIS REPORTS
Volume 14, Issue 6, Pages 579-587

Publisher

CURRENT MEDICINE GROUP
DOI: 10.1007/s11883-012-0285-5

Keywords

Obesity; Diabetes mellitus; Bariatric surgery; Metabolic surgery; Diabetes remission; Weight loss

Funding

  1. Ethicon Endosurgery
  2. Cinemed
  3. Quadrant Healthcare

Ask authors/readers for more resources

Obesity is associated with a variety of weight-related metabolic comorbidities. Bariatric surgery (metabolic/gastrointestinal surgery) not only achieves significant and sustainable weight loss, but also induces extraordinary effects on nearly all obesity-related comorbidities, particularly remission of type 2 diabetes mellitus (T2DM). The mechanisms underlying such effects are slowly being elucidated, and it appears that the metabolic benefits of bariatric surgery are not only attributable to weight loss, but there are also weight independent mechanisms at play. This article outlines the metabolic effects of the most commonly performed bariatric procedures, with a particular emphasis on how they affect glucose metabolism and T2DM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available